Jennifer E. Thorne, MD, PhD, discusses evidence from the ADJUST trial, including relapse risk, retreatment success, and how clinicians should monitor children when considering adalimumab discontinuation.
Jennifer E. Thorne, MD, PhD
Advertisement
Jennifer E. Thorne, MD, PhD, is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine in Baltimore, Maryland.
Articles by Jennifer E. Thorne, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
International meta-analysis highlights elevated ocular risk in Clade I Monkeypox
5